or
forgot password

    • cancer clinical trials in tucson, AZ

    • Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
    University of Arizona Cancer Center
    Tucson, Arizona 85724
    Ovarian Neoplasms
    A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery
    Northwest NeuroSpecialists, PPLC
    Tucson, Arizona 85741
    Cardiovascular, Neurologic (Spine), and General Surgery
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Sarcoma
    PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma
    University of Arizona/Arizona Cancer Center
    Tucson, Arizona 85724
    Neoplasm
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Malignant Mesothelioma
    Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Breast Cancer
    Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma
    University of Arizona Cancer Center
    Tucson, Arizona 85724
    Melanoma
    DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
    Southern Arizona VA Healthcare System

    Trial Locations
    Southern Arizona VA Healthcare System
    U of Arizona / Arizona Cancer Center
    Prostate Cancer
    A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
    University of Arizona Cancer Center
    Tucson, Arizona 85724
    Myelodysplastic Syndrome
    Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
    Visions Clinical Research-Tucson
    Tucson, Arizona 85712
    Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia
    Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
    Arizona Cancer Center
    Tucson, Arizona 85724
    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome
    Pancreatic Cancer Serum and DNA Repository
    University of Arizona/Arizona Cancer Center
    Tucson, Arizona 85724
    Pancreas Cancer
    Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Cervical Cancer, Precancerous Condition
    PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Arizona Oncology - Tucson
    Tucson, Arizona 85704
    Brain and Central Nervous System Tumors
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Neuroblastoma
    A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
    Arizona Cancer Center
    Tucson, Arizona 85724
    Thrombosis, Cancer, Pulmonary Embolism
    Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
    University of Arizona Cancer Center
    Tucson, Arizona 85724
    Malignant Ascites
    Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Pancreatic Adenocarcinoma
    Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Intraocular Retinoblastoma
    The Second Multicenter Hemophilia Cohort Study
    University of Arizona
    Tucson, Arizona 85724
    Liver Decompensation, Hepatocellular Carcinoma, Non-Hodgkin Lymphoma
    Pilots of Self-Collection for HPV DNA Detection
    University of Arizona
    Tucson, Arizona 85724
    HPV
    APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Arizona Clinical Research Center, Incorporated
    Tucson, Arizona 85715
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Sarcoma
    Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
    Arizona Cancer Center
    Tucson, Arizona 85724
    Non-small Cell Lung Cancer
    Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Anxiety Disorder, Colorectal Cancer, Depression, Psychosocial Effects of Cancer and Its Treatment
    A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
    Arizona Cancer Center
    Tucson, Arizona 85724
    Acute Myelogenous Leukemia, Acute Myeloid Leukemia
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
    Arizona Clinical Research Center, Inc.
    Tucson, Arizona 85712
    Fallopian Tube Cancer, Peritoneal Neoplasms, Ovarian Cancer
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    ACRC/Arizona Clinical Research Center, Inc.
    Tucson, Arizona 85712
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    TroVax Renal Immunotherapy Survival Trial
    AZ Cancer Center
    Tucson, Arizona 85724
    Clear Cell Renal Carcinoma
    Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Cognitive/Functional Effects, Colorectal Cancer, Long-term Effects Secondary to Cancer Therapy in Adults
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Southern Arizona VA Health Care System

    Trial Locations
    Southern Arizona VA Health Care System
    Pima Research Foundation
    Southwest Heart
    Atrial Fibrillation, Atrial Flutter
    Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
    Arizona Cancer Center
    Tucson, Arizona 85724
    Ovarian, Melanoma, Renal, Prostate, Colorectal, Endometrial Carcinoma, Cervical Carcinoma, Testicular Cancer, Thyroid Cancer, Small Cell Lung Carcinoma, Mesothelioma, Breast Carcinoma, Esophageal Carcinoma, Gastric Cancer, Pancreatic Carcinoma, Neuroendocrine Cancer, Liver Cancer, Gallbladder Cancer, Biliary Tract Cancer, Anal Carcinoma, Bone Sarcomas, Soft Tissue Sarcomas, Carcinoma of Unknown Origin, Primary
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Non-Small Cell Lung Cancer
    Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma
    Arizona Cancer Center
    Tucson, Arizona 85724
    Soft Tissue Sarcoma
    Safety and Efficacy Study of Glufosfamide in Ovarian Cancer
    Arizona Cancer Center
    Tucson, Arizona 85724
    Ovarian Cancer
    Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Adrenocortical Carcinoma, Localized Resectable Neuroblastoma, Precancerous Condition
    Assessment and Tracking of Long-term Alefacept Safety
    Sheftel & Associates Dermatology
    Tucson, Arizona 85718
    Psoriasis
    Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
    Arizona Cancer Center - Tucson
    Tucson, Arizona 85724-5024
    Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer
    Diarrhea Predominant Irritable Bowel Syndrome in Females
    Genova Clinical Research
    Tucson, Arizona 85741
    Irritable Bowel Syndrome
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Sarcoma
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Leukemia
    AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Pancreatic Cancer
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    Arizona Cancer Center
    Tucson, Arizona 85724
    Melanoma
    Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer
    University of Arizona / University Medical Center
    Tucson, Arizona 85724
    Metastatic Brain Cancer
    Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
    ACRC/Arizona Clinical Research Center, Inc.
    Tucson, Arizona 85712
    Lung Cancer, Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    Northwest NeuroSpecialists, PLLC
    Tucson, Arizona
    Multiple Sclerosis, Relapsing-Remitting
    A Study of Ramucirumab With or Without Dacarbazine in Metastatic Malignant Melanoma
    ImClone Investigational Site
    Tucson, Arizona 85712
    Metastatic Malignant Melanoma
    PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
    Arizona Clinical Research Center, Incorporated
    Tucson, Arizona 85715
    Lung Cancer
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Arizona Oncology Associates
    Tucson, Arizona 85712-2254
    Small Cell Lung Cancer
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    Northwest NeuroSpecialists, PLLC
    Tucson, Arizona
    Multiple Sclerosis, Relapsing-Remitting
    Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
    University of Arizona Medical Center, Arizona Cancer Center
    Tucson, Arizona 85724
    Pancreatic Cancer